Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | Molecular profile impacts platelet function and thrombin generation in essential thrombocythemia

Mercedes Gasior Kabat • 22 Jun 2021
EHA 2021
Essential Thrombocythemia Myeloproliferative Neoplasms Rare Diseases

Mercedes Gasior Kabat, MD, Hospital Universitario La Paz, Madrid, Spain, discusses the relationship between molecular profile, platelet activity and thrombin generation in patients with essential thrombocythemia. Comparison of data from 22 adult patients with essential thrombocythemia and 10 healthy controls demonstrated that the molecular profile of patients with essential thrombocythemia, such as the presence JAK2 mutations or MPL mutations, may impact platelet activity and thrombin generation. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

More from Mercedes Gasior Kabat

2:41
T-cell depletion targeting CD45RA in HLA-mismatched HSCT
Mercedes Gasior Kabat • 22 Jun 2021
3:13
Donor NK cell infusion to prevent HHV6 reactivation in pediatric patients
Mercedes Gasior Kabat • 1 Sep 2020
3:06
Safety and outcome of prophylactic high-dose donor CD45RO+ memory T-cells after allo-HSCT
Mercedes Gasior Kabat • 31 Aug 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals